Johnson & Johnson Reports 2020 First-Quarter Results:

New Brunswick, N.J. (April 14, 2020) – Johnson &Johnson (NYSE: JNJ) today announced results for first-quarter 2020. The Company also announced earlier today that its Board of Directors declared a 6.3% increase in the quarterly dividend rate, from $0.95 per share to $1.01 per share. At the new rate, the indicated dividend on an annual basis is $4.04 per share compared to the previous rate of $3.80 per share. “With Johnson &Johnson’s century-plus history of leading in times of great challenge, we are mobilizing our resources across the Company in the fight against the COVID-19 pandemic,” said Alex Gorsky, Chairman and Chief Executive Officer. “Johnson &Johnson is built for times like this, and we are leveraging our scientific expertise, operational scale and financial strength in the effort to advance the work on our lead COVID-19 vaccine candidate. We are committed to beginning production at risk imminently and bringing an affordable and accessible vaccine to the public on a not-for-profit basis for emergency pandemic use.” Mr. Gorsky continued, “I am both proud and amazed at the level of dedication that I have witnessed from our more than 132,000 employees as we have focused on delivering on our commitments and responsibilities to the patients and consumers we serve. Our strong performance in the first quarter reflects the efforts of our teams around the world and the sustainability of our business model. Today, our Board ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news

Related Links:

This article is licensed under aCreative Commons Attribution-NonCommercial 3.0 Unported Licence.Bjoern C Froehlich, Robert Popp, Constance A Sobsey, Sahar Ibrahim, Andre M LeBlanc, Yassene Mohammed, Marguerite Buchanan, Adriana Aguilar-Mahecha, Oliver Poetz, Michael X Chen, Alan Spatz, Mark Basik, Gerald Batist, Rene Zahedi, Christoph H. Borchers The PI3-kinase/AKT/mTOR pathway plays a central role in cancer signaling. While p110 α is the catalytic α-subunit of PI3-kinase and a major drug target, PTEN is the main negative regulator of... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Analyst latest articles - Category: Chemistry Authors: Source Type: research
Millions of people stand to lose their Medicaid coverage once special federal pandemic rules for continuous Medicaid enrollment protection come to an end.       
Source: The Commonwealth Fund: Blog - Category: International Medicine & Public Health Authors: Source Type: blogs
The COVID-19 pandemic led to a global increase in hate crimes and xenophobia. In these uncertain times, real or imaginary threats can easily lead to intergroup conflict. Here, we integrate social neuroscience findings with classic social psychology theorie...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news
Adopting a structural violence approach, this article explores, with survivors and practitioners, how early coronavirus disease-2019 pandemic conditions affected forced migrant sexual and gender-based violence survivors' lives. Introducing a new analytical...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
We aimed to discuss the impact of the coronavirus pandemic on the VAW scenario and how it affects women's mental health. The short communication from secondary data collected from the official websites of seven countries in Latin America was performed. The...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
The coronavirus disease of 2019 (COVID-19) pandemic has led to increases in intimate partner violence (IPV), a leading cause of women's homelessness. Although the Canadian Government provided emergency funding to the violence against women and housing and ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
[The publisher has not provided an abstract for this article.] Language: en...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
BACKGROUND: Physical function worsens with older age, particularly for sedentary and socially isolated individuals, and this often leads to injuries. Through reductions in physical activity, the COVID-19 pandemic may have worsened physical function and led...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
BACKGROUND: The COVID-19 pandemic has caused tremendous changes in daily living, which may be related to mental health problems, including psychotic experiences, though research has only begun to assess these associations. METHODS: We analyzed data...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Hawaii officials are facing pressure to increase COVID-19 testing for travelers
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
More News: Anemia | Aspirin | Cancer | Cancer & Oncology | Cancer Vaccines | Cardiology | Chemotherapy | Chronic Kidney Disease | Conferences | COVID-19 | Department of Health | Dexamethasone | Emergency Medicine | Environmental Health | Epogen | European Medicines Agency (EMA) | Food and Drug Administration (FDA) | Gene Therapy | Genetics | Government | Health Management | Heart | Hormones | Hypertension | Ibuprofen | Invega | Invega Sustenna | Legislation | Lung Cancer | Marketing | Medical Devices | Multiple Sclerosis | Myeloma | New Drug Applications | Non-Small Cell Lung Cancer | Oral Cancer | Orthopaedics | Outbreaks | Pandemics | Partnerships | Pediatrics | Peripheral Vascular Disease (PVD) | Pharmaceuticals | Podcasts | Prezista | Procrit | Profits and Losses | Prostate Cancer | Psoriasis | Remicade | Respiratory Medicine | Retinitis Pigmentosa | Schizophrenia | Science | Skin | Stelara | Strategic Planning | Study | Urology & Nephrology | Vaccines | Velcade | Websites | Women | Zyrtec